Tasly Holding Group
Tianjin, Tianjintasly.com
Overview
Tasly Holding Group, founded in 1994, is a high-tech business group oriented to globalization and dedicated to the health sector, focusing on biopharmaceutical and digital intelligent health . Tasly manufactures and distributes chemical medicine, biological medicine, healthcare products, traditional Chinese medicine (TCM), functional food and other products . The company's product line includes herbal medicine, chemical medicine, prescription drugs, pharmaceutical substances, health products, active pharmaceutical ingredients (APIs), herbal extract, tea, cosmetics, daily hygiene product series, and medical equipment .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Synceres Biosciences | Jun 2023 | Series A Extension | Co-investor |
| Triastek | Jun 2021 | Series B | Co-investor |
| Keya Medical | Nov 2020 | Series C | Co-investor |
| Westlake Therapeutics | Jun 2020 | Pre Seed | Co-investor |
| Zhiyun Health | Jan 2020 | Series C Extension | - |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
